Industry: Service & Software
Published Date: 2026-07-15
Pages: 112 Pages
Report ld: 6943437
Request Sample
Customized Report
CRISPR Technology Market Size(US$)

CAGR 2026-2032
19.1%
Market Size,2032
USD 4,711
Million
Market Snapshot
Source: Secondary research, interviews with experts, and QYResearch analysis
The global market for CRISPR Technology was estimated to be worth US$ 1410 million in 2025 and is projected to reach US$ 4711 million, growing at a CAGR of 19.1% from 2026 to 2032.
The North American market for CRISPR Technology was valued at US$ million in 2025 and is projected to reach US$ million by 2032, at a CAGR of % from 2026 to 2032.
The Asia-Pacific market for CRISPR Technology was valued at $ million in 2025 and is projected to climb to US$ million by 2032, at a CAGR of % from 2026 to 2032.
The European market for CRISPR Technology was valued at $ million in 2025 and is projected to total US$ million by 2032, at a CAGR of % from 2026 to 2032.
The global key companies in the CRISPR Technology market include Thermo Fisher Scientific, Merck KGaA, GenScript, Integrated DNA Technologies (IDT), Horizon Discovery Group, Agilent Technologies, Cellecta, GeneCopoeia, New England Biolabs, Origene Technologies, etc. In 2025, the five largest players accounted for approximately % of revenue.
This report provides a comprehensive view of the global market for CRISPR Technology, covering total sales revenue, the market share and ranking of key companies, along with analyses by region & country, by Type, and by Application.
The CRISPR Technology market size, estimations, and forecasts are presented in terms of sales revenue ($ millions), with 2025 as the base year and historical and forecast data from 2021 to 2032. The report combines quantitative and qualitative analysis to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current marketplace, and make informed business decisions regarding CRISPR Technology.
MARKET SEGMENTATION
CHAPTER OUTLINE
Chapter 1: Introduces the scope of the report and the global market size (value). It also summarizes market dynamics and recent developments; identifies key drivers and restraints; outlines challenges and risks for players; reviews relevant industry policies.
Chapter 2: Provides a detailed analysis of the CRISPR Technology companies' competitive landscape—including revenue shares, recent development plans, and mergers and acquisitions (M&A).
Chapter 3: Analyzes market segmentation by Type, presenting the size and growth potential of each segment to help readers identify blue-ocean opportunities.
Chapter 4: Analyzes market segmentation by Application, presenting the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
Chapter 5: Presents CRISPR Technology revenue at the regional level. It offers a quantitative assessment of market size and growth potential by region and summarizes market development, future prospects, addressable space, and country-level market size worldwide.
Chapter 6: Presents CRISPR Technology revenue at the country level. It provides segmented data by Type and by Application for each country/region.
Chapter 7: Profiles key players, detailing the main companies' product revenue, gross margin, product portfolios, recent developments, etc.
Chapter 8: Analysis of Value Chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Market Overview
1.1 CRISPR Technology Product Introduction
1.2 Global CRISPR Technology Market Size Forecast (2021–2032)
1.3 CRISPR Technology Market Trends & Drivers
1.3.1 CRISPR Technology Industry Trends
1.3.2 CRISPR Technology Market Drivers & Opportunities
1.3.3 CRISPR Technology Market Challenges
1.3.4 CRISPR Technology Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global CRISPR Technology Players Revenue Ranking (2025)
2.2 Global CRISPR Technology Revenue by Company (2021–2026)
2.3 Key Companies’ R&D and Operations Footprint and Headquarters
2.4 Key Companies CRISPR Technology Product Offerings
2.5 Key Companies General Availability (GA) Timeline for CRISPR Technology
2.6 CRISPR Technology Market Competitive Analysis
2.6.1 CRISPR Technology Market Concentration Rate (2021–2026)
2.6.2 Top 5 and Top 10 Global Companies by CRISPR Technology Revenue in 2025
2.6.3 Global Companies by Tier (Tier 1, Tier 2, Tier 3), based on CRISPR Technology revenue, 2025
2.7 Mergers & Acquisitions and Expansion
3 Segmentation CRISPR Technology Market Classification
3.1 Introduction by Type
3.1.1 CRISPR Enzymes
3.1.2 CRISPR Libraries
3.1.3 CRISPR Kits
3.1.4 Others
3.1.5 Global CRISPR Technology Sales Value by Type
3.1.5.1 Global CRISPR Technology Sales Value by Type (2021 vs 2025 vs 2032)
3.1.5.2 Global CRISPR Technology Sales Value, by Type (2021–2032)
3.1.5.3 Global CRISPR Technology Sales Value, by Type (%), 2021–2032
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Biomedical
4.1.2 Agricultural
4.2 Global CRISPR Technology Sales Value by Application
4.2.1 Global CRISPR Technology Sales Value by Application (2021 vs 2025 vs 2032)
4.2.2 Global CRISPR Technology Sales Value by Application (2021–2032)
4.2.3 Global CRISPR Technology Sales Value by Application (%), 2021–2032
5 Segmentation by Region
5.1 Global CRISPR Technology Sales Value by Region
5.1.1 Global CRISPR Technology Sales Value by Region: 2021 vs 2025 vs 2032
5.1.2 Global CRISPR Technology Sales Value by Region (2021–2026)
5.1.3 Global CRISPR Technology Sales Value by Region (2027–2032)
5.1.4 Global CRISPR Technology Sales Value by Region (%), 2021–2032
5.2 North America
5.2.1 North America CRISPR Technology Sales Value, 2021–2032
5.2.2 North America CRISPR Technology Sales Value by Country (%), 2025 vs 2032
5.3 Europe
5.3.1 Europe CRISPR Technology Sales Value, 2021–2032
5.3.2 Europe CRISPR Technology Sales Value by Country (%), 2025 vs 2032
5.4 Asia Pacific
5.4.1 Asia Pacific CRISPR Technology Sales Value, 2021–2032
5.4.2 Asia Pacific CRISPR Technology Sales Value by Subregion (%), 2025 vs 2032
5.5 South America
5.5.1 South America CRISPR Technology Sales Value, 2021–2032
5.5.2 South America CRISPR Technology Sales Value by Country (%), 2025 vs 2032
5.6 Middle East & Africa
5.6.1 Middle East & Africa CRISPR Technology Sales Value, 2021–2032
5.6.2 Middle East & Africa CRISPR Technology Sales Value by Country (%), 2025 vs 2032
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions CRISPR Technology Sales Value Growth Trends, 2021 vs 2025 vs 2032
6.2 Key Countries/Regions CRISPR Technology Sales Value, 2021–2032
6.3 United States
6.3.1 United States CRISPR Technology Sales Value, 2021–2032
6.3.2 United States CRISPR Technology Sales Value by Type (%), 2025 vs 2032
6.3.3 United States CRISPR Technology Sales Value by Application, 2025 vs 2032
6.4 Europe
6.4.1 Europe CRISPR Technology Sales Value, 2021–2032
6.4.2 Europe CRISPR Technology Sales Value by Type (%), 2025 vs 2032
6.4.3 Europe CRISPR Technology Sales Value by Application, 2025 vs 2032
6.5 China
6.5.1 China CRISPR Technology Sales Value, 2021–2032
6.5.2 China CRISPR Technology Sales Value by Type (%), 2025 vs 2032
6.5.3 China CRISPR Technology Sales Value by Application, 2025 vs 2032
6.6 Japan
6.6.1 Japan CRISPR Technology Sales Value, 2021–2032
6.6.2 Japan CRISPR Technology Sales Value by Type (%), 2025 vs 2032
6.6.3 Japan CRISPR Technology Sales Value by Application, 2025 vs 2032
6.7 South Korea
6.7.1 South Korea CRISPR Technology Sales Value, 2021–2032
6.7.2 South Korea CRISPR Technology Sales Value by Type (%), 2025 vs 2032
6.7.3 South Korea CRISPR Technology Sales Value by Application, 2025 vs 2032
6.8 Southeast Asia
6.8.1 Southeast Asia CRISPR Technology Sales Value, 2021–2032
6.8.2 Southeast Asia CRISPR Technology Sales Value by Type (%), 2025 vs 2032
6.8.3 Southeast Asia CRISPR Technology Sales Value by Application, 2025 vs 2032
6.9 India
6.9.1 India CRISPR Technology Sales Value, 2021–2032
6.9.2 India CRISPR Technology Sales Value by Type (%), 2025 vs 2032
6.9.3 India CRISPR Technology Sales Value by Application, 2025 vs 2032
7 Company Profiles
7.1 Thermo Fisher Scientific
7.1.1 Thermo Fisher Scientific Profile
7.1.2 Thermo Fisher Scientific Main Business
7.1.3 Thermo Fisher Scientific CRISPR Technology Products, Services, and Solutions
7.1.4 Thermo Fisher Scientific CRISPR Technology Revenue (US$ Million), 2021–2026
7.1.5 Thermo Fisher Scientific Recent Developments
7.2 Merck KGaA
7.2.1 Merck KGaA Profile
7.2.2 Merck KGaA Main Business
7.2.3 Merck KGaA CRISPR Technology Products, Services, and Solutions
7.2.4 Merck KGaA CRISPR Technology Revenue (US$ Million), 2021–2026
7.2.5 Merck KGaA Recent Developments
7.3 GenScript
7.3.1 GenScript Profile
7.3.2 GenScript Main Business
7.3.3 GenScript CRISPR Technology Products, Services, and Solutions
7.3.4 GenScript CRISPR Technology Revenue (US$ Million), 2021–2026
7.3.5 GenScript Recent Developments
7.4 Integrated DNA Technologies (IDT)
7.4.1 Integrated DNA Technologies (IDT) Profile
7.4.2 Integrated DNA Technologies (IDT) Main Business
7.4.3 Integrated DNA Technologies (IDT) CRISPR Technology Products, Services, and Solutions
7.4.4 Integrated DNA Technologies (IDT) CRISPR Technology Revenue (US$ Million), 2021–2026
7.4.5 Integrated DNA Technologies (IDT) Recent Developments
7.5 Horizon Discovery Group
7.5.1 Horizon Discovery Group Profile
7.5.2 Horizon Discovery Group Main Business
7.5.3 Horizon Discovery Group CRISPR Technology Products, Services, and Solutions
7.5.4 Horizon Discovery Group CRISPR Technology Revenue (US$ Million), 2021–2026
7.5.5 Horizon Discovery Group Recent Developments
7.6 Agilent Technologies
7.6.1 Agilent Technologies Profile
7.6.2 Agilent Technologies Main Business
7.6.3 Agilent Technologies CRISPR Technology Products, Services, and Solutions
7.6.4 Agilent Technologies CRISPR Technology Revenue (US$ Million), 2021–2026
7.6.5 Agilent Technologies Recent Developments
7.7 Cellecta
7.7.1 Cellecta Profile
7.7.2 Cellecta Main Business
7.7.3 Cellecta CRISPR Technology Products, Services, and Solutions
7.7.4 Cellecta CRISPR Technology Revenue (US$ Million), 2021–2026
7.7.5 Cellecta Recent Developments
7.8 GeneCopoeia
7.8.1 GeneCopoeia Profile
7.8.2 GeneCopoeia Main Business
7.8.3 GeneCopoeia CRISPR Technology Products, Services, and Solutions
7.8.4 GeneCopoeia CRISPR Technology Revenue (US$ Million), 2021–2026
7.8.5 GeneCopoeia Recent Developments
7.9 New England Biolabs
7.9.1 New England Biolabs Profile
7.9.2 New England Biolabs Main Business
7.9.3 New England Biolabs CRISPR Technology Products, Services, and Solutions
7.9.4 New England Biolabs CRISPR Technology Revenue (US$ Million), 2021–2026
7.9.5 New England Biolabs Recent Developments
7.10 Origene Technologies
7.10.1 Origene Technologies Profile
7.10.2 Origene Technologies Main Business
7.10.3 Origene Technologies CRISPR Technology Products, Services, and Solutions
7.10.4 Origene Technologies CRISPR Technology Revenue (US$ Million), 2021–2026
7.10.5 Origene Technologies Recent Developments
7.11 Synthego Corporation
7.11.1 Synthego Corporation Profile
7.11.2 Synthego Corporation Main Business
7.11.3 Synthego Corporation CRISPR Technology Products, Services, and Solutions
7.11.4 Synthego Corporation CRISPR Technology Revenue (US$ Million), 2021–2026
7.11.5 Synthego Corporation Recent Developments
7.12 Toolgen
7.12.1 Toolgen Profile
7.12.2 Toolgen Main Business
7.12.3 Toolgen CRISPR Technology Products, Services, and Solutions
7.12.4 Toolgen CRISPR Technology Revenue (US$ Million), 2021–2026
7.12.5 Toolgen Recent Developments
8 Industry Chain Analysis
8.1 CRISPR Technology Value Chain
8.2 CRISPR Technology Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Key Suppliers of Raw Materials
8.2.3 Cost Structure
8.3 Midstream Analysis
8.4 Downstream (Customer) Analysis
8.5 Sales Model and Sales Channelss
8.5.1 CRISPR Technology Sales Model
8.5.2 Sales Channels
8.5.3 CRISPR Technology Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global CRISPR Technology market was valued at US$ 1410 million in 2025 and is anticipated to reach US$ 4711 million by 2032, at a CAGR of 19.1% from 2026 to 2032.
Published Date: 2026-04-27
Pages: 113
USD 2900.00
(Single User License)
The global CRISPR Technology market size was US$ 1203 million in 2024 and is forecast to a readjusted size of US$ 4020 million by 2031 with a CAGR of 19.1% during the forecast period 2025-2031.
Published Date: 2025-09-06
Pages: 97
USD 4250.00
(Single User License)
The global market for CRISPR Technology was estimated to be worth US$ 1203 million in 2024 and is forecast to a readjusted size of US$ 4020 million by 2031 with a CAGR of 19.1% during the forecast period 2025-2031.
Published Date: 2025-02-27
Pages: 101
USD 3950.00
(Single User License)
The global market for CRISPR Technology was valued at US$ 1203 million in the year 2024 and is projected to reach a revised size of US$ 4020 million by 2031, growing at a CAGR of 19.1% during the forecast period.
Published Date: 2025-02-27
Pages: 87
USD 2900.00
(Single User License)
Market Analysis and Insights: Global CRISPR Technology Market
Published Date: 2024-04-15
Pages: 109
USD 4900.00
(Single User License)
The global market for CRISPR Technology was estimated to be worth US$ 845 million in 2023 and is forecast to a readjusted size of US$ 2928.2 million by 2030 with a CAGR of 19.1% during the forecast period 2024-2030
Published Date: 2024-01-24
Pages: 106
USD 3950.00
(Single User License)
The global CRISPR Technology market was valued at US$ 845 million in 2023 and is anticipated to reach US$ 2928.2 million by 2030, witnessing a CAGR of 19.1% during the forecast period 2024-2030.
Published Date: 2024-01-04
Pages: 87
USD 2900.00
(Single User License)
The global CRISPR Technology market was valued at US$ 1410 million in 2025 and is anticipated to reach US$ 4711 million by 2032, at a CAGR of 19.1% from 2026 to 2032.
Published: 2026-04-27
Pages: 113
The global CRISPR Technology market size was US$ 1203 million in 2024 and is forecast to a readjusted size of US$ 4020 million by 2031 with a CAGR of 19.1% during the forecast period 2025-2031.
Published: 2025-09-06
Pages: 97
The global market for CRISPR Technology was estimated to be worth US$ 1203 million in 2024 and is forecast to a readjusted size of US$ 4020 million by 2031 with a CAGR of 19.1% during the forecast period 2025-2031.
Published: 2025-02-27
Pages: 101
The global market for CRISPR Technology was valued at US$ 1203 million in the year 2024 and is projected to reach a revised size of US$ 4020 million by 2031, growing at a CAGR of 19.1% during the forecast period.
Published: 2025-02-27
Pages: 87
Market Analysis and Insights: Global CRISPR Technology Market
Published: 2024-04-15
Pages: 109
The global market for CRISPR Technology was estimated to be worth US$ 845 million in 2023 and is forecast to a readjusted size of US$ 2928.2 million by 2030 with a CAGR of 19.1% during the forecast period 2024-2030
Published: 2024-01-24
Pages: 106
The global CRISPR Technology market was valued at US$ 845 million in 2023 and is anticipated to reach US$ 2928.2 million by 2030, witnessing a CAGR of 19.1% during the forecast period 2024-2030.
Published: 2024-01-04
Pages: 87
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now